Clinical Trial Update: Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for immunotherapy using ex vivo expanded haploidentical natural killer cells in children and young adults with acute myeloid leukemia (Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ex vivo expanded haploidentical natural killer cells

Snippet

Sponsor: Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING